查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1565074

胡佛針的全球市場

Huber Needles
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 194 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

到 2030 年，全球胡佛針市場預計將達到 9,430 萬美元

胡佛針的全球市場預計 2023 年為 6,780 萬美元，預計到 2030 年將達到 9,430 萬美元，2023-2030 年分析期間複合年成長率為 4.8%。靜脈癌症治療應用是本報告分析的細分市場之一，預計複合年成長率為 5.4%，到分析期結束時將達到 4,570 萬美元。分析期間，輸血應用領域的複合年成長率預計為 4.3%。

美國市場預估為1,840萬美元，中國預期複合年成長率為4.5%

預計 2023 年美國胡佛針市場規模將達 1,840 萬美元。中國作為世界第二大經濟體，預計2030年市場規模將達到1,480萬美元，2023-2030年分析期間複合年成長率為4.5%。其他值得注意的區域市場包括日本和加拿大，在分析期間預計複合年成長率分別為 4.7% 和 3.7%。在歐洲，德國的複合年成長率預計為 3.9%。

全球胡佛針市場—主要趨勢與促進因素總結

胡佛針是安全有效長期用藥的關鍵嗎？

胡佛針已成為現代醫療保健的重要工具，但為什麼它們對於安全有效的長期給藥至關重要？胡佛針是一種沒有取芯的專用針，設計用於進入植入的血管通路裝置，例如需要長期靜脈治療的患者使用的端口。這些針頭廣泛用於接受化療、輸血和長期靜脈治療的患者，提供了一種可靠、安全的給藥方式，無需反覆刺穿靜脈。

胡佛針的吸引力在於其獨特的設計，可最大程度地減少組織損傷並降低取芯風險（小塊組織被切斷並引入血液中）。這使其成為需要頻繁或長期訪問中心靜脈港的患者的理想選擇。胡佛針既舒適又安全，確保治療有效進行，沒有不必要的疼痛或併發症。隨著醫療保健提供者尋求改善慢性病護理環境中的患者照護，胡佛針對於保持血管通路裝置的完整性、同時最大限度地減少不適和風險至關重要。

科技如何改進 Huber 針？

技術進步顯著提高了 Huber 針的安全性、功能性和易用性，使其更有效、更可靠地進行長期給藥。最重要的進步之一是引入了安全設計的 Huber 針。這些針頭配備了安全機制，可保護醫護人員免受意外針刺，避免接觸血源性病原體。許多 Huber 針頭均標配安全功能，例如自動針頭回縮和防護，以降低受傷風險並促進臨床環境中更安全的工作環境。

材料和塗層的改進也提高了胡佛針的性能。現代胡佛針通常由先進的不銹鋼製成，具有耐用性、靈活性和生物相容性。有些針頭具有塗層，可以減少插入過程中的摩擦，使過程更順暢，患者更舒適。這種塗層還有助於最大限度地減少對周圍組織的創傷，並減少端口部位刺激和感染的可能性。

除了安全性和材料改進之外，Huber 針的設計也經過改進，以提高準確性和患者舒適度。許多較新的型號具有傾斜或符合人體工學的設計，以便於醫療保健專業人員操作和精確定位。這會減少插入過程中的併發症，並使患者更穩定地進入連接埠。此外，人體工學設計提高了護理人員和醫生的整體可用性，因為他們經常需要在複雜的高壓環境中處理這些針頭。

流量控制胡佛針是另一個重要的進步。這些針灸針旨在改善藥物通過針頭的流動並更有效地確保劑量。對於化療和輸血，確保準確和穩定的流速對於治療效果和病人安全至關重要。流量控制的 Huber 針減少了阻塞和不一致輸送的機會，這可能會影響患者照護。

更細規格的 Huber 針的出現也擴大了 Huber 針的用途。細針在插入過程中可減少疼痛和組織損傷，對於需要頻繁治療的患者來說特別舒適。這些細針可最大程度地減少不適，同時保持有效的端口通路，使它們對兒科患者以及皮膚和組織敏感的患者特別有益。

為什麼胡佛針對長期患者照護和藥物輸送至關重要？

Huber 針對長期患者照護和藥物傳遞至關重要，因為它們為需要頻繁靜脈注射治療的患者提供了一種安全、可靠且微創的進入血管端口的方法。許多接受化療、慢性疼痛治療​​和長期靜脈注射治療的患者受益於植入式端口，這些端口允許醫療保健專業人員將治療直接注入血液中。胡佛針經過專門設計，可以在不損壞這些端口的情況下進入這些端口，從而使它們能夠長時間保持功能。

胡佛針的主要優點之一是其無穿刺設計。 Huber 針在刺穿血管端口時不會解剖組織，從而降低了取芯和血流污染的風險。此功能對於保持端口完整性和防止感染和阻塞等併發症至關重要。確保端口的使用壽命和安全對於依賴端口進行救生治療的患者至關重要，而 Huber 針在這過程中發揮關鍵作用。

Huber 針還可以透過減少重複針刺帶來的疼痛和創傷來提高患者的舒適度。當多次使用傳統針頭進入端口時，會造成嚴重的不適和組織損傷。然而，Huber 針的設計最大限度地減少了組織創傷，使其成為長期治療方法的首選。這對於需要連續數月或數年每週或每天訪問端口的化療患者尤其重要。使用胡佛針可以最大程度地減少疼痛、降低感染風險並改善患者的整體健康。

胡佛針重要的另一個原因是安全和受控的藥物輸送。對於化療等需要精確劑量和時間安排的治療，Huber 針可確保藥物直接進入血液，而不會出現併發症。其可靠性對於降低藥物洩漏或阻塞的風險至關重要，藥物洩漏或阻塞會影響治療效果。此外，它與各種輸注療法和輸注速率相容，使其可用於從化療到腸外營養的各種臨床應用。

胡佛針對於保護醫護人員也至關重要。胡佛針整合了安全設計功能，有助於防止意外針刺，從而傳播愛滋病毒和肝炎等血感染疾病。在醫護人員每天處理大量針頭的繁忙臨床環境中，胡佛針的​​安全功能提供了額外的保護層，確保在不讓工作人員面臨風險的情況下進行治療。

推動胡佛針市場成長的因素有哪些？

胡佛針市場成長的因素有很多，包括慢性病盛行率的上升、化療和其他長期治療需求的增加以及針安全技術的進步。主要促進因素之一是需要長期靜脈治療的患者數量不斷增加，特別是正在接受癌症治療的患者。隨著全球癌症發生率的上升，越來越多的患者正在接受化療，通常使用血管通路裝置，例如端口。對安全可靠地存取這些裝置的需求導致對 Huber 針的需求增加，Huber 針為連接埠存取提供了一種非刺穿、舒適且有效的解決方案。

擴大使用植入式輸液港來治療各種慢性疾病也是推動市場成長的關鍵因素。輸液港不僅用於治療腫瘤，還用於治療自體免疫疾病、慢性疼痛以及需要透過腸外營養進行長期營養支持的患者。隨著此類治療變得越來越普遍，對能夠安全進入輸液港且無併發症的 Huber 針的需求將繼續成長。

針頭安全技術的進步也推動了市場的擴張。對針刺傷和相關健康風險的認知不斷提高，人們越來越重視開發和採用安全設計的 Huber 針。這些針頭降低了意外接觸血源性病原體的風險，保護了醫護人員和病人。對改善醫療機構職業安全的關注導致安全針頭的廣泛採用，促進了胡佛針頭市場的整體成長。

人口老化也是市場成長的一個主要因素。隨著世界人口老化，癌症、心血管疾病、糖尿病等慢性病患者數量不斷增加。其中許多患者需要長期靜脈注射治療或定期血管端口通路，這推動了對胡佛針的需求。此外，老年患者的靜脈更加脆弱，使得 Huber 針成為最大程度地減少組織損傷並確保治療期間舒適的首選。

胡佛針設計和材料的技術進步也促進了市場的成長。使胡佛針更加準確、舒適和安全的創新使其對醫療保健提供者更具吸引力。更細的針頭、人體工學設計和先進的安全功能的開發提高了患者和醫療保健專業人員的使用便利性。隨著這些創新的進步，胡佛針的​​市場預計將進一步擴大，醫療保健提供者尋求最好的工具來提供長期、優質的照護。

對以病人為中心的照護的日益關注也是影響胡佛針市場成長的因素。隨著醫療保健提供者越來越注重改善接受長期治療的患者的生活品質，對能夠最大限度地減少不適和併發症的醫療設備的需求不斷成長。胡佛針透過專注於緩解疼痛和保護血管端口的設計來滿足這些目標，使其成為患者照護策略的重要組成部分。

由於慢性病的增加、安全技術的進步以及對長期治療解決方案的需求不斷成長，胡佛針市場預計將持續成長。隨著醫療保健提供者優先考慮安全、效率和患者舒適度，胡佛針將繼續成為跨各種醫學學科安全有效地提供關鍵治療的重要工具。

調查企業範例（共41例）

  • AngioDynamics, Inc.
  • B. Braun Medical, Inc.
  • BARD, A Becton, Dickinson Company
  • Baxter International, Inc.
  • EXELINT International Co.
  • Nipro Medical Corporation
  • Smiths Medical
  • Thibaut SAS
  • Vygon SA

目錄

第1章調查方法

第 2 章執行摘要

  • 市場概況
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 其他歐洲國家
  • 亞太地區
  • 其他領域

第4章 比賽

簡介目錄
Product Code: MCP12448

Global Huber Needles Market to Reach US$94.3 Million by 2030

The global market for Huber Needles estimated at US$67.8 Million in the year 2023, is expected to reach US$94.3 Million by 2030, growing at a CAGR of 4.8% over the analysis period 2023-2030. IV Cancer Treatment Application, one of the segments analyzed in the report, is expected to record a 5.4% CAGR and reach US$45.7 Million by the end of the analysis period. Growth in the Blood Transfusions Application segment is estimated at 4.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$18.4 Million While China is Forecast to Grow at 4.5% CAGR

The Huber Needles market in the U.S. is estimated at US$18.4 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$14.8 Million by the year 2030 trailing a CAGR of 4.5% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 4.7% and 3.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.9% CAGR.

Global Huber Needles Market - Key Trends and Drivers Summarized

Are Huber Needles the Key to Safe and Efficient Long-Term Medication Delivery?

Huber needles have become an indispensable tool in modern healthcare, but why are they so essential for the safe and efficient delivery of medications over extended periods? A Huber needle is a specialized, non-coring needle designed to access implanted vascular access devices, such as ports used in patients requiring long-term intravenous (IV) treatments. These needles are widely used in patients undergoing chemotherapy, blood transfusions, or long-term IV therapy, as they provide a reliable and safe way to administer medication without repeatedly puncturing veins.

The appeal of Huber needles lies in their unique design, which minimizes tissue damage and reduces the risk of coring (where a small piece of tissue is cut and introduced into the bloodstream). This makes them ideal for patients who need frequent or long-term access to central venous ports. Huber needles offer both comfort and safety, ensuring that treatments are delivered effectively without causing unnecessary pain or complications. As healthcare providers seek to enhance patient care in chronic treatment settings, Huber needles are critical for maintaining the integrity of vascular access devices while minimizing discomfort and risk.

How Has Technology Advanced Huber Needles?

Technological advancements have significantly improved the safety, functionality, and ease of use of Huber needles, making them more efficient and reliable for long-term medication delivery. One of the most important developments is the introduction of safety-engineered Huber needles. These needles are equipped with safety mechanisms that protect healthcare workers from accidental needlestick injuries, which can expose them to bloodborne pathogens. Safety features like automatic needle retraction or shielding have become standard in many Huber needles, reducing the risk of injury and promoting a safer work environment in clinical settings.

Improved materials and coatings have also enhanced the performance of Huber needles. Modern Huber needles are often made with advanced stainless steel, which provides durability, flexibility, and biocompatibility. Some needles feature coatings that reduce friction during insertion, making the process smoother and more comfortable for patients. These coatings can also help minimize trauma to the surrounding tissue, reducing irritation and the potential for infection around the port site.

In addition to safety and material improvements, the design of Huber needles has become more refined, with innovations that enhance precision and patient comfort. Many newer models have angled or ergonomic designs that make them easier for healthcare providers to handle and position accurately. This leads to fewer complications during insertion and more consistent access to the patient’s port. Additionally, the ergonomic design improves the overall user experience for nurses and doctors, who must often handle these needles in complex, high-pressure environments.

Flow-controlled Huber needles represent another significant advancement. These needles are designed to improve the flow of medication or fluids through the needle, ensuring that dosages are administered more efficiently. In the context of chemotherapy or blood transfusions, ensuring accurate and steady flow rates is crucial for both the efficacy of treatment and patient safety. Flow-controlled Huber needles help reduce the likelihood of blockages or inconsistent delivery, which can compromise patient care.

The availability of smaller gauge Huber needles has also expanded the applications of these devices. Smaller gauge needles cause less pain and tissue damage upon insertion, making them more comfortable for patients, especially those requiring frequent treatments. These finer needles are particularly beneficial for pediatric patients or individuals with more sensitive skin or tissue, as they minimize discomfort while maintaining effective port access.

Why Are Huber Needles Critical for Long-Term Patient Care and Medication Delivery?

Huber needles are critical for long-term patient care and medication delivery because they provide a safe, reliable, and less invasive method for accessing vascular ports in patients who require frequent IV treatments. Many patients undergoing chemotherapy, chronic pain management, or long-term IV therapy benefit from implanted ports, which allow healthcare providers to administer treatments directly into the bloodstream. Huber needles are specially designed to access these ports without damaging them, ensuring that the port remains functional over extended periods.

One of the primary advantages of Huber needles is their non-coring design. When a Huber needle punctures a vascular port, it does not remove tissue, thereby reducing the risk of coring and contamination of the bloodstream. This feature is essential for maintaining the integrity of the port and preventing complications such as infections or blockages. For patients who depend on their ports for life-saving treatments, ensuring the longevity and safety of the port is crucial, and Huber needles play a vital role in this process.

Huber needles also improve patient comfort by reducing the pain and trauma associated with repeated needle insertions. Traditional needles can cause significant discomfort and tissue damage when used to access a port multiple times. However, the design of Huber needles minimizes tissue trauma, making them a preferred option for long-term treatment regimens. This is especially important in chemotherapy patients, who may need weekly or even daily access to their ports over the course of several months or years. The use of Huber needles helps minimize pain, reduces the risk of infection, and promotes better overall patient well-being.

The safe and controlled delivery of medications is another reason why Huber needles are so important. In treatments such as chemotherapy, where precise dosing and timing are essential, Huber needles ensure that the medication is delivered directly into the bloodstream without complications. Their reliability is critical in reducing the risk of drug leaks, blockages, or other issues that could compromise the efficacy of treatment. Additionally, their compatibility with a wide range of IV therapies and infusion rates makes them versatile for various clinical applications, from chemotherapy to parenteral nutrition.

Huber needles are also vital for the protection of healthcare workers. With the integration of safety-engineered features, Huber needles help prevent accidental needlestick injuries, which can transmit bloodborne diseases such as HIV or hepatitis. In busy clinical environments where healthcare workers may handle multiple needles daily, the safety features of Huber needles provide an added layer of protection, ensuring that treatments are administered without putting staff at risk.

What Factors Are Driving the Growth of the Huber Needles Market?

Several factors are driving the growth of the Huber needles market, including the rising prevalence of chronic diseases, increasing demand for chemotherapy and other long-term treatments, and advancements in needle safety technology. One of the primary drivers is the growing number of patients requiring long-term intravenous therapies, particularly those undergoing cancer treatment. As the global incidence of cancer rises, more patients are being treated with chemotherapy, often through vascular access devices like ports. The need for safe and reliable access to these devices is contributing to the increased demand for Huber needles, which offer a non-coring, comfortable, and effective solution for port access.

The expanding use of implanted ports for a variety of chronic conditions is another key factor fueling market growth. Ports are not only used in oncology but also in patients with autoimmune diseases, chronic pain conditions, or those needing long-term nutrition support via parenteral nutrition. As these treatments become more common, the demand for Huber needles that can safely access these ports without causing complications will continue to grow.

Advancements in needle safety technology are also driving market expansion. With increased awareness of needlestick injuries and the associated health risks, there is a growing emphasis on the development and adoption of safety-engineered Huber needles. These needles reduce the risk of accidental exposure to bloodborne pathogens, protecting both healthcare workers and patients. The focus on improving occupational safety in healthcare settings has led to wider adoption of safety needles, contributing to the overall growth of the Huber needles market.

The aging population is another significant driver of market growth. As the global population ages, the number of individuals living with chronic diseases such as cancer, cardiovascular conditions, and diabetes is increasing. Many of these patients require long-term IV therapies or regular access to vascular ports, driving the demand for Huber needles. Additionally, elderly patients may have more delicate veins, making Huber needles a preferred option for minimizing tissue damage and ensuring comfort during treatments.

Technological advancements in the design and materials used in Huber needles have also contributed to market growth. Innovations that enhance the precision, comfort, and safety of Huber needles have made them more attractive to healthcare providers. The development of smaller gauge needles, more ergonomic designs, and advanced safety features has improved the user experience for both patients and healthcare workers. As these innovations continue, the market for Huber needles is expected to expand further, with healthcare providers seeking the best tools to deliver long-term, high-quality care.

The increasing focus on patient-centered care is another factor influencing the growth of the Huber needles market. As healthcare providers place greater emphasis on improving the quality of life for patients undergoing long-term treatments, there is a growing demand for medical devices that minimize discomfort and complications. Huber needles, with their design focused on reducing pain and protecting vascular ports, align with these goals, making them a critical component in patient care strategies.

With the rising prevalence of chronic diseases, advancements in safety technology, and the growing need for long-term treatment solutions, the Huber needles market is poised for continued growth. As healthcare providers prioritize safety, efficiency, and patient comfort, Huber needles will remain an essential tool in ensuring the safe and effective delivery of critical therapies across various medical disciplines.

Select Competitors (Total 41 Featured) -

  • AngioDynamics, Inc.
  • B. Braun Medical, Inc.
  • BARD, A Becton, Dickinson Company
  • Baxter International, Inc.
  • EXELINT International Co.
  • Nipro Medical Corporation
  • Smiths Medical
  • Thibaut SAS
  • Vygon SA

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Global Economic Update
    • Huber Needles - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Demand for Oncology and Chronic Disease Management Drives Growth in Huber Needles Market
    • Expansion of Intravenous Drug Administration and Parenteral Nutrition Spurs Adoption of Huber Needles
    • Growth in Use of Huber Needles for Long-term Vascular Access Expands Addressable Market
    • Role of Huber Needles in Enhancing Patient Comfort and Reducing Needle-stick Injuries Strengthens Business Case for Adoption
    • Growth in Use of Huber Needles in Chemotherapy and Blood Transfusions Expands Market Opportunities
    • Role of Huber Needles in Supporting Home-based Infusion Therapy and Parenteral Nutrition Expands Addressable Market
    • Growth in Use of Huber Needles in Central Venous Catheterization and Port Access Strengthens Market Demand
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Huber Needles Market Analysis of Annual Sales in US$ for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Huber Needles by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Huber Needles by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 4: World 16-Year Perspective for Huber Needles by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for IV Cancer Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 6: World Historic Review for IV Cancer Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 7: World 16-Year Perspective for IV Cancer Treatment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Blood Transfusions by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Blood Transfusions by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 10: World 16-Year Perspective for Blood Transfusions by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Dialysis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Dialysis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 13: World 16-Year Perspective for Dialysis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Lap-Band Adjustments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Lap-Band Adjustments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 16: World 16-Year Perspective for Lap-Band Adjustments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Home Parenteral Nutrition by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Home Parenteral Nutrition by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 19: World 16-Year Perspective for Home Parenteral Nutrition by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 22: World 16-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Curved Display by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Curved Display by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 25: World 16-Year Perspective for Curved Display by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Straight by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Straight by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 28: World 16-Year Perspective for Straight by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Huber Needles Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 29: USA Recent Past, Current & Future Analysis for Huber Needles by Application - IV Cancer Treatment, Blood Transfusions, Dialysis, Lap-Band Adjustments, Home Parenteral Nutrition and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Huber Needles by Application - IV Cancer Treatment, Blood Transfusions, Dialysis, Lap-Band Adjustments, Home Parenteral Nutrition and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 31: USA 16-Year Perspective for Huber Needles by Application - Percentage Breakdown of Value Sales for IV Cancer Treatment, Blood Transfusions, Dialysis, Lap-Band Adjustments, Home Parenteral Nutrition and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 32: USA Recent Past, Current & Future Analysis for Huber Needles by Type - Curved Display and Straight - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Huber Needles by Type - Curved Display and Straight Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 34: USA 16-Year Perspective for Huber Needles by Type - Percentage Breakdown of Value Sales for Curved Display and Straight for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 35: Canada Recent Past, Current & Future Analysis for Huber Needles by Application - IV Cancer Treatment, Blood Transfusions, Dialysis, Lap-Band Adjustments, Home Parenteral Nutrition and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 36: Canada Historic Review for Huber Needles by Application - IV Cancer Treatment, Blood Transfusions, Dialysis, Lap-Band Adjustments, Home Parenteral Nutrition and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 37: Canada 16-Year Perspective for Huber Needles by Application - Percentage Breakdown of Value Sales for IV Cancer Treatment, Blood Transfusions, Dialysis, Lap-Band Adjustments, Home Parenteral Nutrition and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 38: Canada Recent Past, Current & Future Analysis for Huber Needles by Type - Curved Display and Straight - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Canada Historic Review for Huber Needles by Type - Curved Display and Straight Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 40: Canada 16-Year Perspective for Huber Needles by Type - Percentage Breakdown of Value Sales for Curved Display and Straight for the Years 2014, 2024 & 2030
  • JAPAN
    • Huber Needles Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 41: Japan Recent Past, Current & Future Analysis for Huber Needles by Application - IV Cancer Treatment, Blood Transfusions, Dialysis, Lap-Band Adjustments, Home Parenteral Nutrition and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 42: Japan Historic Review for Huber Needles by Application - IV Cancer Treatment, Blood Transfusions, Dialysis, Lap-Band Adjustments, Home Parenteral Nutrition and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 43: Japan 16-Year Perspective for Huber Needles by Application - Percentage Breakdown of Value Sales for IV Cancer Treatment, Blood Transfusions, Dialysis, Lap-Band Adjustments, Home Parenteral Nutrition and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 44: Japan Recent Past, Current & Future Analysis for Huber Needles by Type - Curved Display and Straight - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Japan Historic Review for Huber Needles by Type - Curved Display and Straight Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 46: Japan 16-Year Perspective for Huber Needles by Type - Percentage Breakdown of Value Sales for Curved Display and Straight for the Years 2014, 2024 & 2030
  • CHINA
    • Huber Needles Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 47: China Recent Past, Current & Future Analysis for Huber Needles by Application - IV Cancer Treatment, Blood Transfusions, Dialysis, Lap-Band Adjustments, Home Parenteral Nutrition and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 48: China Historic Review for Huber Needles by Application - IV Cancer Treatment, Blood Transfusions, Dialysis, Lap-Band Adjustments, Home Parenteral Nutrition and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 49: China 16-Year Perspective for Huber Needles by Application - Percentage Breakdown of Value Sales for IV Cancer Treatment, Blood Transfusions, Dialysis, Lap-Band Adjustments, Home Parenteral Nutrition and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 50: China Recent Past, Current & Future Analysis for Huber Needles by Type - Curved Display and Straight - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 51: China Historic Review for Huber Needles by Type - Curved Display and Straight Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 52: China 16-Year Perspective for Huber Needles by Type - Percentage Breakdown of Value Sales for Curved Display and Straight for the Years 2014, 2024 & 2030
  • EUROPE
    • Huber Needles Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Huber Needles by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Huber Needles by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 55: Europe 16-Year Perspective for Huber Needles by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Huber Needles by Application - IV Cancer Treatment, Blood Transfusions, Dialysis, Lap-Band Adjustments, Home Parenteral Nutrition and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 57: Europe Historic Review for Huber Needles by Application - IV Cancer Treatment, Blood Transfusions, Dialysis, Lap-Band Adjustments, Home Parenteral Nutrition and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 58: Europe 16-Year Perspective for Huber Needles by Application - Percentage Breakdown of Value Sales for IV Cancer Treatment, Blood Transfusions, Dialysis, Lap-Band Adjustments, Home Parenteral Nutrition and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 59: Europe Recent Past, Current & Future Analysis for Huber Needles by Type - Curved Display and Straight - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 60: Europe Historic Review for Huber Needles by Type - Curved Display and Straight Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 61: Europe 16-Year Perspective for Huber Needles by Type - Percentage Breakdown of Value Sales for Curved Display and Straight for the Years 2014, 2024 & 2030
  • FRANCE
    • Huber Needles Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 62: France Recent Past, Current & Future Analysis for Huber Needles by Application - IV Cancer Treatment, Blood Transfusions, Dialysis, Lap-Band Adjustments, Home Parenteral Nutrition and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 63: France Historic Review for Huber Needles by Application - IV Cancer Treatment, Blood Transfusions, Dialysis, Lap-Band Adjustments, Home Parenteral Nutrition and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 64: France 16-Year Perspective for Huber Needles by Application - Percentage Breakdown of Value Sales for IV Cancer Treatment, Blood Transfusions, Dialysis, Lap-Band Adjustments, Home Parenteral Nutrition and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 65: France Recent Past, Current & Future Analysis for Huber Needles by Type - Curved Display and Straight - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 66: France Historic Review for Huber Needles by Type - Curved Display and Straight Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 67: France 16-Year Perspective for Huber Needles by Type - Percentage Breakdown of Value Sales for Curved Display and Straight for the Years 2014, 2024 & 2030
  • GERMANY
    • Huber Needles Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 68: Germany Recent Past, Current & Future Analysis for Huber Needles by Application - IV Cancer Treatment, Blood Transfusions, Dialysis, Lap-Band Adjustments, Home Parenteral Nutrition and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Germany Historic Review for Huber Needles by Application - IV Cancer Treatment, Blood Transfusions, Dialysis, Lap-Band Adjustments, Home Parenteral Nutrition and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 70: Germany 16-Year Perspective for Huber Needles by Application - Percentage Breakdown of Value Sales for IV Cancer Treatment, Blood Transfusions, Dialysis, Lap-Band Adjustments, Home Parenteral Nutrition and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 71: Germany Recent Past, Current & Future Analysis for Huber Needles by Type - Curved Display and Straight - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 72: Germany Historic Review for Huber Needles by Type - Curved Display and Straight Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 73: Germany 16-Year Perspective for Huber Needles by Type - Percentage Breakdown of Value Sales for Curved Display and Straight for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 74: Italy Recent Past, Current & Future Analysis for Huber Needles by Application - IV Cancer Treatment, Blood Transfusions, Dialysis, Lap-Band Adjustments, Home Parenteral Nutrition and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 75: Italy Historic Review for Huber Needles by Application - IV Cancer Treatment, Blood Transfusions, Dialysis, Lap-Band Adjustments, Home Parenteral Nutrition and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 76: Italy 16-Year Perspective for Huber Needles by Application - Percentage Breakdown of Value Sales for IV Cancer Treatment, Blood Transfusions, Dialysis, Lap-Band Adjustments, Home Parenteral Nutrition and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 77: Italy Recent Past, Current & Future Analysis for Huber Needles by Type - Curved Display and Straight - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 78: Italy Historic Review for Huber Needles by Type - Curved Display and Straight Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 79: Italy 16-Year Perspective for Huber Needles by Type - Percentage Breakdown of Value Sales for Curved Display and Straight for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Huber Needles Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 80: UK Recent Past, Current & Future Analysis for Huber Needles by Application - IV Cancer Treatment, Blood Transfusions, Dialysis, Lap-Band Adjustments, Home Parenteral Nutrition and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 81: UK Historic Review for Huber Needles by Application - IV Cancer Treatment, Blood Transfusions, Dialysis, Lap-Band Adjustments, Home Parenteral Nutrition and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 82: UK 16-Year Perspective for Huber Needles by Application - Percentage Breakdown of Value Sales for IV Cancer Treatment, Blood Transfusions, Dialysis, Lap-Band Adjustments, Home Parenteral Nutrition and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 83: UK Recent Past, Current & Future Analysis for Huber Needles by Type - Curved Display and Straight - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 84: UK Historic Review for Huber Needles by Type - Curved Display and Straight Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 85: UK 16-Year Perspective for Huber Needles by Type - Percentage Breakdown of Value Sales for Curved Display and Straight for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 86: Rest of Europe Recent Past, Current & Future Analysis for Huber Needles by Application - IV Cancer Treatment, Blood Transfusions, Dialysis, Lap-Band Adjustments, Home Parenteral Nutrition and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Rest of Europe Historic Review for Huber Needles by Application - IV Cancer Treatment, Blood Transfusions, Dialysis, Lap-Band Adjustments, Home Parenteral Nutrition and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 88: Rest of Europe 16-Year Perspective for Huber Needles by Application - Percentage Breakdown of Value Sales for IV Cancer Treatment, Blood Transfusions, Dialysis, Lap-Band Adjustments, Home Parenteral Nutrition and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 89: Rest of Europe Recent Past, Current & Future Analysis for Huber Needles by Type - Curved Display and Straight - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Rest of Europe Historic Review for Huber Needles by Type - Curved Display and Straight Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 91: Rest of Europe 16-Year Perspective for Huber Needles by Type - Percentage Breakdown of Value Sales for Curved Display and Straight for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Huber Needles Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 92: Asia-Pacific Recent Past, Current & Future Analysis for Huber Needles by Application - IV Cancer Treatment, Blood Transfusions, Dialysis, Lap-Band Adjustments, Home Parenteral Nutrition and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Asia-Pacific Historic Review for Huber Needles by Application - IV Cancer Treatment, Blood Transfusions, Dialysis, Lap-Band Adjustments, Home Parenteral Nutrition and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 94: Asia-Pacific 16-Year Perspective for Huber Needles by Application - Percentage Breakdown of Value Sales for IV Cancer Treatment, Blood Transfusions, Dialysis, Lap-Band Adjustments, Home Parenteral Nutrition and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 95: Asia-Pacific Recent Past, Current & Future Analysis for Huber Needles by Type - Curved Display and Straight - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Asia-Pacific Historic Review for Huber Needles by Type - Curved Display and Straight Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 97: Asia-Pacific 16-Year Perspective for Huber Needles by Type - Percentage Breakdown of Value Sales for Curved Display and Straight for the Years 2014, 2024 & 2030
  • REST OF WORLD
    • TABLE 98: Rest of World Recent Past, Current & Future Analysis for Huber Needles by Application - IV Cancer Treatment, Blood Transfusions, Dialysis, Lap-Band Adjustments, Home Parenteral Nutrition and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Rest of World Historic Review for Huber Needles by Application - IV Cancer Treatment, Blood Transfusions, Dialysis, Lap-Band Adjustments, Home Parenteral Nutrition and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 100: Rest of World 16-Year Perspective for Huber Needles by Application - Percentage Breakdown of Value Sales for IV Cancer Treatment, Blood Transfusions, Dialysis, Lap-Band Adjustments, Home Parenteral Nutrition and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 101: Rest of World Recent Past, Current & Future Analysis for Huber Needles by Type - Curved Display and Straight - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Rest of World Historic Review for Huber Needles by Type - Curved Display and Straight Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 103: Rest of World 16-Year Perspective for Huber Needles by Type - Percentage Breakdown of Value Sales for Curved Display and Straight for the Years 2014, 2024 & 2030

IV. COMPETITION